Celanese Corporation is a Fortune 500 global technology and specialty materials company headquartered in Irving, Texas, United States.
72 articles
Celanese Corp. shares rose 4.56% after-hours to EUR 41.06, following an announcement of price increases for certain engineered-materials products effective October 8, 2026.
Celanese Corporation shares rose 6.89 percent to close at USD 47.44, outperforming the S&P 500 amid rising acetyl-chain prices. The rally follows an earlier 8.3 percent increase driven by similar comm
Celanese Corp. shares rose 8.3% after raising prices on acetyl products to recover margins, following a Q2 earnings beat. Analyst views remain divided despite the stock performance.
Celanese Corporation announced global price hikes for acetyl products such as acetic acid and vinyl acetate monomer. The move follows a flat stock close at USD 52.91 and is expected to impact future p
Celanese Corp. shares dropped 2.92% despite beating Q2 EPS estimates, as profit gains stemmed from margins rather than revenue. Analysts hold a Moderate Buy rating with a USD 63.27 price target, signa
Celanese Corp. shares closed at $46.81 amid valuation debates, as the company plans to sell a 19% stake in its Nutrinova unit to Mitsui for $152 million. Earnings beat expectations, yet long-term shar
Celanese Corp. shares rose 3.61% to $46.26 on Wednesday, breaking a two-day losing streak, although the gain trailed broader market indices.
Celanese Corp director Kim K.W. Rucker acquired 8.705 phantom stock units valued at $44.46 each under the 2008 Deferred Compensation Plan, increasing total holdings to 12,909.224 units.
Celanese Corp Senior Vice President and General Counsel Ashley B. Duffie purchased 600 shares at $45.6 per share on August 11, 2026. Her direct ownership increased to 31,925 shares following the SEC F
Celanese Corporation director Edward G. Galante received equity-based compensation awards, increasing his direct stock holdings to nearly 28,000 shares. The transactions were filed on a Form 4 as non-
Norges Bank disclosed a passive 9.6 million share stake in Celanese Corp, representing 8.8% of outstanding stock, via a Schedule 13G/A filing.
Celanese Corporation shares rose 1.88% to $43.95, outperforming broader market indices during a poor trading session. Despite gains, the stock remains significantly below its 52-week high.
Celanese Corporation reported 2026 quarterly revenue of $2.75 billion, despite year-over-year declines in net income and EPS due to portfolio changes. Growth was driven by higher pricing in its Acetyl
Baird reduced its target price for Celanese Corp shares from $75 to $65, according to a Reuters report dated August 6, 2026.
Celanese Corp shares rose 3.08% to $45.24, outperforming broader market indices and ending a two-day losing streak during a strong trading session.
Celanese Corp receives a 7.44 earnings forecast score with analyst consensus favoring a Buy rating. The report details projected revenue growth and EPS performance relative to peers in the Chemicals i
TradingKey analyzes Celanese Corp (CE) stock, highlighting healthy fundamentals and high growth potential. Analysts rate it a Buy with a target price of $67.59 despite recent weak market performance.
Celanese Corporation shares rose slightly as financial data highlighted its Engineered Materials and Acetyl Chain segments. The report includes market cap details, executive information, and instituti
Celanese Corporation shares rose 4.20% to $48.36, outperforming declining broader market indices like the S&P 500. This marks the second consecutive day of gains for the company despite overall weak t
Celanese Corp. shares dropped 1.13% to $47.21 on Wednesday, extending losses for a second day despite gains in the S&P 500 and Dow Jones.
Celanese Corporation declared a quarterly cash dividend of $0.03 per share, payable on August 10, 2026, to stockholders of record as of July 28, 2026. The global chemistry leader continues its shareho
Celanese Corp. shares fell 1.40% to close at $46.64, marking its second consecutive day of losses while broader indices gained.
Celanese Corp. shares fell 2.83% to $47.30, though the headline suggests outperformance against competitors. The stock remains 33.10% below its 52-week high reached in May.
Celanese Corp. shares fell 1.74% to $45.20 on Wednesday, underperforming the broader market and closing significantly below its 52-week high of $70.70.
Celanese Corporation shares are highlighted by analysts focusing on its engineered materials and acetyl products. The report provides live price data and NYSE trading context without offering investme
Celanese Corp emphasizes long-term strategy focusing on debt reduction and capital returns within its specialty chemicals segments. Investors watch how this plan sustains cash generation across its gl
Celanese Corporation is refining its focus on specialty materials and acetyl chains while integrating recent acquisitions like DuPont Mobility & Materials. Analysts monitor its performance as it seeks
The NYSE filed a Form 25 to withdraw the listing of Celanese Corp.'s 4.777% Senior Notes Due 2026 following voluntary procedures. This action removes the security from the national exchange, potential
Celanese Corporation shares rose 1.83% to close at $48.92 on Thursday, ending a six-day losing streak, though the gain trailed behind competitors.
Celanese Corp. shares fell 3.22% to $48.13 on Tuesday, marking five consecutive days of losses amid a broader market decline where the S&P 500 fell 1.44%.
ChemBrief